Zhiguang Zhou Selected Research

Glutamate Decarboxylase (Decarboxylase, Glutamate)

1/2022	Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.
1/2022	GAD65 Antibody Epitopes and Genetic Background in Latent Autoimmune Diabetes in Youth (LADY).
1/2022	Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages.
1/2022	rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes.
7/2021	The polymorphism of the CARD8 inflammasome-related gene is associated with glutamic-acid-decarboxylase-antibody positivity in patients with type 1 diabetes mellitus.
1/2021	Frequency, clinical features, inflammatory cytokines and genetic background of latent autoimmune diabetes in youth in youth-onset type 2 diabetes: Results from a nationwide, multicentre, clinic-based, cross-sectional study (LADA China).
10/2020	Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.
7/2020	Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
1/2020	Past, present and future of latent autoimmune diabetes in adults.
1/2020	Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiguang Zhou Research Topics

Disease

86	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 03/2005
67	Type 2 Diabetes Mellitus (MODY) 03/2022 - 11/2003
30	Latent Autoimmune Diabetes in Adults 08/2022 - 11/2003
21	Insulin Resistance 03/2022 - 01/2005
19	Obesity 05/2022 - 01/2013
18	Inflammation (Inflammations) 01/2022 - 03/2005
12	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 08/2014
12	Hyperglycemia 01/2022 - 06/2011
11	Body Weight (Weight, Body) 12/2021 - 06/2011
9	Diabetes Mellitus 06/2022 - 04/2002
9	Hypoglycemia (Reactive Hypoglycemia) 06/2022 - 01/2013
8	Diabetes Complications 01/2022 - 11/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2010
8	Atherosclerosis 01/2020 - 04/2010
7	Neoplasms (Cancer) 01/2021 - 01/2013
6	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 04/2015
5	Insulinoma 01/2022 - 10/2012
5	Infections 04/2021 - 04/2013
5	Ketosis 01/2020 - 03/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 06/2015
4	Prediabetic State (Prediabetes) 08/2021 - 03/2010
4	Weight Gain 05/2020 - 01/2017
4	Dyslipidemias (Dyslipidemia) 03/2019 - 11/2003
4	Glucose Intolerance 08/2014 - 03/2010
4	Hypertension (High Blood Pressure) 11/2013 - 11/2003
3	COVID-19 01/2021 - 01/2020
3	Weight Loss (Weight Reduction) 01/2021 - 11/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2010
3	Virus Diseases (Viral Diseases) 10/2020 - 01/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 03/2015
3	Disease Progression 01/2019 - 01/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2014 - 05/2013
2	Iron Deficiencies 05/2022 - 01/2021
2	Hypersensitivity (Allergy) 10/2021 - 01/2011
2	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021 - 07/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2015
2	Pathologic Processes 01/2021 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 08/2017

Drug/Important Bio-Agent (IBA)

56	Insulin (Novolin)FDA Link 10/2022 - 11/2003
29	AutoantibodiesIBA 01/2022 - 11/2003
28	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2010
21	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 11/2003
14	C-PeptideIBA 11/2021 - 11/2003
11	Proteins (Proteins, Gene)FDA Link 07/2021 - 07/2010
10	Blood Glucose (Blood Sugar)IBA 06/2022 - 07/2010
10	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
9	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2013
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2022 - 07/2010
7	LipidsIBA 03/2022 - 01/2013
7	Hypoglycemic Agents (Hypoglycemics)IBA 09/2020 - 03/2005
6	Insulin Glargine (Lantus)FDA Link 06/2022 - 11/2016
6	AntigensIBA 06/2021 - 01/2012
6	CytokinesIBA 01/2021 - 01/2015
6	AntibodiesIBA 10/2020 - 06/2011
6	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 01/2014
5	Zinc Transporter 8IBA 01/2022 - 10/2010
5	EnzymesIBA 06/2021 - 06/2015
5	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2014
5	CreatinineIBA 10/2020 - 11/2016
5	Transcription Factors (Transcription Factor)IBA 06/2019 - 12/2013
4	ZincIBA 01/2022 - 10/2010
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 05/2014
4	Fatty Acid-Binding ProteinsIBA 01/2021 - 04/2010
4	C-Reactive ProteinIBA 01/2021 - 01/2005
3	LY2963016 insulin glargineIBA 06/2022 - 10/2021
3	ProinsulinIBA 08/2021 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2016
3	AdiponectinIBA 01/2021 - 03/2010
3	Indicators and Reagents (Reagents)IBA 01/2021 - 09/2012
3	Biological ProductsIBA 01/2021 - 01/2020
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 10/2014
3	Immunoglobulin A (IgA)IBA 12/2020 - 01/2019
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 03/2019
3	Immunoglobulin M (IgM)IBA 01/2019 - 01/2011
3	Histones (Histone)IBA 01/2019 - 10/2014
3	Therapeutic UsesIBA 11/2014 - 09/2012
3	ThiazolidinedionesIBA 04/2013 - 03/2005
2	Ferritins (Ferritin)IBA 05/2022 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 05/2022 - 01/2021
2	EpitopesIBA 01/2022 - 06/2011
2	Galectins (Galectin)IBA 01/2022 - 01/2015
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 04/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021 - 01/2019
2	Insulin AntibodiesIBA 10/2021 - 07/2018
2	transcription factor NF-AT c3IBA 09/2021 - 10/2018
2	InflammasomesIBA 07/2021 - 01/2020
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2021 - 01/2020
2	Acarbose FDA LinkGeneric 01/2021 - 01/2014
2	Monoclonal AntibodiesIBA 01/2021 - 01/2015
2	recombinant interferon alpha 2b-like proteinIBA 01/2021 - 10/2020
2	CholesterolIBA 01/2021 - 04/2010
2	Vitamin D FDA LinkGeneric 01/2021 - 07/2009
2	CalciumIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2015
2	Lipocalin-2IBA 01/2021 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020

Therapy/Procedure

36	Therapeutics 05/2022 - 05/2008
17	Glycemic Control 01/2022 - 01/2013
8	Bariatric Surgery 05/2022 - 11/2018
5	Gastrectomy 05/2022 - 01/2019